Edward S. Kim

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Bayesian Analysis of Binary and Polychotomous Response Data 1993 James H. Albert
Siddhartha Chib
2
+ The method of minimization for allocation to clinical trials 2002 Neil Scott
Gladys McPherson
Craig Ramsay
Marion Campbell
2
+ Randomized Phase II Designs in Cancer Clinical Trials: Current Status and Future Directions 2005 J. Jack Lee
Lei Feng
2
+ Optimality, Variability, Power 2003 Feifang Hu
William F. Rosenberger
2
+ Clinical trials design and treatment tailoring: General principles applied to breast cancer research 2006 P. Therasse
Sylviane Carbonnelle
Jan Bogaerts
2
+ Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments 2005 Peter F. Thall
J. Kyle Wathen
2
+ PDF Chat On the efficiency of targeted clinical trials 2004 A. Maitournam
Richard Simon
2
+ Adaptive Design Methods in Clinical Trials 2010 Shein‐Chung Chow
Mark Chang
2
+ Introduction to Bayesian methods II: fundamental concepts 2005 Thomas A. Louis
2
+ PDF Chat Evaluating the Efficiency of Targeted Designs for Randomized Clinical Trials 2004 Richard Simon
Aboubakar Maitournam
2
+ Ethical issues in oncology biostatistics 2002 Peter F. Thall
2
+ Statistical Innovations in Cancer Research 2017 J. Jack Lee
Donald A. Berry
2
+ Adaptive trial design. 2007 Donald A. Berry
2
+ Bayesian approaches to clinical trials and health-care evaluation 2013 David J. Spiegelhalter
Keith R. Abrams
Jonathan P. Myles
2
+ BIAS CALCULATIONS FOR ADAPTIVE URN DESIGNS 2001 D. Stephen Coad
Anastasia Ivanova
2
+ Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress 2001 Atanu Biswas
2
+ Introduction to Bayesian methods I: measuring the strength of evidence 2005 Steven N. Goodman
2
+ Clinical Trials: A Practical Approach. 1984 Ira Hill
Stuart J. Pocock
2
+ Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial 1975 Stuart J. Pocock
Richard Simon
2
+ Clinical Trial Design for Anticancer Therapies 2007 J. Jack Lee
2
+ The Theory of Response-Adaptive Randomization in Clinical Trials 2006 Feifang Hu
William F. Rosenberger
2
+ PDF Chat Bayesian Statistics and the Efficiency and Ethics of Clinical Trials 2004 Donald A. Berry
2
+ Randomized Play-the-Winner Clinical Trials 1999 William F. Rosenberger
2
+ Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis 2005 Donald A. Berry
2
+ Randomization in Clinical Trials: Theory and Practice 2002 William F. Rosenberger
John M. Lachin
2
+ PDF Chat Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource 2018 Ben Goldacre
Nicholas DeVito
Carl Heneghan
Francis Irving
Seb Bacon
Jessica Fleminger
Helen J Curtis
1
+ PDF Chat Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology 2018 Brian P. Hobbs
Pedro C. Barata
Yada Kanjanapan
Channing J. Paller
Jane Perlmutter
Gregory R. Pond
Tatiana M. Prowell
Eric H. Rubin
Lesley Seymour
Nolan A. Wages
1
+ Phase I trials as valid therapeutic options for patients with cancer 2019 Jacob J. Adashek
Patricia LoRusso
David S. Hong
Razelle Kurzrock
1
+ Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology 2020 Paul Frankel
Vincent Chung
Yan Xing
Jeff Longmate
Susan Groshen
Edward M. Newman
1
+ PDF Chat Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies 2020 Paul Frankel
Vincent Chung
Joseph M. Tuscano
Tanya Siddiqi
Sagus Sampath
Jeff Longmate
Susan Groshen
Edward M. Newman
1
+ The Drug-Dosing Conundrum in Oncology — When Less Is More 2021 Mirat Shah
Atiqur Rahman
Marc R. Theoret
Richard Pazdur
1
+ Randomization in Clinical Trials 2002 William F. Rosenberger
John M. Lachin
1
+ Clinical Trials : A Methodologic Perspective 1997 Steven Piantadosi
1
+ Adaptive Design Theory and Implementation Using SAS and R 2014 Mark Chang
1
+ Reducing patient eligibility criteria in cancer clinical trials. 1996 Stephen L. George
1
+ PDF Chat Bayesian optimal interval designs for phase I clinical trials 2014 Suyu Liu
Ying Yuan
1
+ PDF Chat Adaptive design theory and implementation using SAS and R 2009 Andrew P. Robinson
1
+ The continual reassessment method for dose-finding studies: a tutorial 2006 Elizabeth Garrett‐Mayer
1
+ PDF Chat Critical aspects of the Bayesian approach to phase I cancer trials 2008 Beat Neuenschwander
Michael Branson
Thomas Gsponer
1
+ Design and Analysis of Phase I Clinical Trials 1989 Barry E. Storer
1
+ Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? 2008 Franklin G. Miller
Steven Joffe
1
+ Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer 1990 John O’Quigley
Margaret S. Pepe
Lloyd D. Fisher
1
+ PDF Chat Adaptive Dose-Finding Studies: A Review of Model-Guided Phase I Clinical Trials 2014 Alexia Iasonos
John O’Quigley
1
+ Bayesian clinical trials 2006 Donald A. Berry
1
+ Modernizing Eligibility Criteria for Molecularly Driven Trials 2015 Edward S. Kim
David Bernstein
Susan G. Hilsenbeck
Christine H. Chung
Adam P. Dicker
Jennifer L. Ersek
Steven Stein
Fadlo R. Khuri
Earle F. Burgess
Kelly K. Hunt
1
+ PDF Chat Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design 2008 Jeffrey Skolnik
Jeffrey S. Barrett
Bhuvana Jayaraman
Dimple Patel
Peter C. Adamson
1
+ PDF Chat Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go? 2002 Christopher R. Palmer
1
+ PDF Chat A modified toxicity probability interval method for dose-finding trials 2010 Yuan Ji
Ping Liu
Yisheng Li
B. Nebiyou Bekele
1
+ PDF Chat Accelerated Titration Designs for Phase I Clinical Trials in Oncology 1997 Richard Simon
Larry Rubinstein
Susan G. Arbuck
Michaele C. Christian
Boris Freidlin
Jerry M. Collins
1
+ Adaptive Design Methods in Clinical Trials 2007 Angela Wade
1